Print  |  Font Size Change Font Size
Search naabt.org  

The National Alliance of Advocates
for Buprenorphine Treatment

Buprenorphine (Suboxone®, Subutex®) is an opioid medication used to treat opioid
addiction in the privacy of a physician's office.1 Buprenorphine can be dispensed
for take-home use, by prescription.1 This, in addition to the pharmacological and safety
profile of buprenorphine, makes it an attractive treatment for patients addicted to opioids.2

Patient / Physician Matching System

If you have been unable to find appropriate buprenorphine treatment, you may register on the patient/physician matching system.

At no time will naabt.org ask for your name or publish your email address, you will be assigned a NAABT ID number and that is what the doctor will see. The only time you will need to identify yourself is when you arrange for an appointment with a doctor, confidentially on the telephone. If you wish further anonymity, you may sign up for a 3rd party email address, at hotmail or yahoo. Counselors may sign up on behalf of a patient who may not have access to a computer.

How it Works

  1. Place yourself on the list, anonymously and confidentially.

  2. Certified treatment providers will review applicants.

  3. When a treatment provider has an opening and/or matches the criteria they will email you, and ask you to contact them to further discuss your treatment

Read More

 


Secure • Confidential

Patient Application

Male    Female
years
Oxycodone  Hydrocodone   Methadone  Heroin 
Buprenorphine  Morphine  Other opioid pain killers
Cold Turkey  Rapid Detox  Rehab Facility
Methadone  Buprenorphine Other
miles
Yes    No
Yes    No
Yes    No
Yes    No
Yes    No
(400 Character Limit)

Characters Left


* Physicians cannot see your email address.




Terms:
These terms are in addition to the terms listed for our entire site.
 
This site is for US residents 18 years old or older. 

NAABT,Inc. acts only as an optional and additional tool to help connect individuals in need of buprenorphine treatment to buprenorphine treatment providers. DO NOT rely on it for your only path to healthcare. If you need immediate attention go to an emergency room, call 911, or seek immediate healthcare from a qualified healthcare provider.

NAABT, Inc. serves to assist people in finding Buprenorphine treatment providers only, like that of a search engine, telephone book, or map. It is entirely your responsibility to determine if the physician is appropriately credentialed and not misrepresenting him/her self in any way. NAABT does not endorse nor is responsible for any action of the physicians or patients who use our service. The service is free and voluntary, and comes with no warranty or guarantee, or cost for using the service.

Inclusion of a member physician is not and does not imply any NAABT referral, endorsement or recommendation, nor does the omission of any individual indicate any NAABT disapproval.

 
No Medical Advice or Doctor-Patient Relationship
Information contained on or made available through the Site is NOT intended to and does NOT constitute medical advice, recommendations or counseling under any circumstance and no doctor-patient relationship is formed. We do not warranty or guarantee the accuracy, completeness, adequacy or currency of the information contained in or linked to the site. Your use of information and services on the Site or materials linked to the Site is entirely at your own risk.
 
Information contained on this website is not intended to substitute for the expertise and advice of your physician(s), counselor(s), pharmacist(s) or other qualified healthcare professional(s).  It should not be interpreted as a claim that use of the treatment is safe, appropriate or effective for you. It is entirely your responsibility to consult your healthcare professional before using this or any treatment.
 
THE INFORMATION, CONTENT AND DOCUMENTS FROM OR THROUGH THE SITE ARE PROVIDED "AS-IS," "AS AVAILABLE", WITH “ALL FAULTS”, AND ALL WARRANTIES, EXPRESS OR IMPLIED, ARE DISCLAIMED (INCLUDING BUT NOT LIMITED TO THE DISCLAIMER OF ANY IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE). THE INFORMATION AND SERVICES MAY CONTAIN BUGS, ERRORS, PROBLEMS OR OTHER LIMITATIONS.

This page was last modified on : 10/08/2009
National Drug & Alcohol Recovery MonthAddiction Survivors National Institute of HealthAlcohol AnswersNIDA
  1. U.S. Food and Drug Administration, FDA Talk Paper, T0238, October 8, 2002, Subutex and Suboxone approved to treat opiate dependence.
  2. Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, Md: Substance Abuse and Mental Health Services Administration, 2004.